{"id":"NCT01697956","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 6-Week Study Designed to Investigate the Effects of BDP Nasal Aerosol on the Hypothalamic-Pituitary-Adrenal (HPA)-Axis in Pediatric Subjects (6 to 11 Years of Age) With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-10","primaryCompletion":"2013-02","completion":"2013-02","firstPosted":"2012-10-02","resultsPosted":"2015-10-08","lastUpdate":"2015-10-08"},"enrollment":99,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"BDP","otherNames":["QNASLÂ®","Beclomethasone dipropionate"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"BDP Nasal Aerosol 80 mcg/day","type":"EXPERIMENTAL"},{"label":"Placebo Nasal Aerosol","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the effect of 6 weeks of treatment with beclomethasone dipropionate (BDP) nasal aerosol versus placebo on HPA-axis function, as assessed by 24-hour serum cortisol weighted mean, and to evaluate the safety and tolerability of BDP nasal aerosol, in subjects 6 to 11 years of age with perennial allergic rhinitis.","primaryOutcome":{"measure":"Change From Baseline (Expressed As A Ratio) In 24-Hr Serum Cortisol Weighted Mean Following 6 Weeks Of Treatment","timeFrame":"Baseline (Day 1, -24, -22, -20, -16, -12, -8, and 0 hours prior to study medication), End of Treatment (Day 43, (Immediately prior to study medication administration (Hour 0) and at 2, 4, 8, 12, 16, and 24 hours after study medication administration)","effectByArm":[{"arm":"BDP Nasal Aerosol 80 mcg/Day","deltaMin":1.04,"sd":1.037},{"arm":"Placebo Nasal Aerosol","deltaMin":1.1,"sd":1.053}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":6,"countries":["United States"]},"refs":{"pmids":["26250771"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":67},"commonTop":["Epistaxis","Pyrexia","Upper respiratory tract infection","Arthralgia"]}}